ERBB2 and cancer: With the defined tumor-promoting functions of tumor-infiltrating macrophages34, we speculate that the lack of tumor attack by macrophages in radioresistant cancer cells is at least in part due to the enhanced immune-defending capacity by HER2–NF-κB-mediated CD47 enrichment.